Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Drugs for Skin Aging
NCT03072485Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Feb 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sirolimus, metformin 1% gel and diclofenac in Skin aging (2 arms). Primary endpoint: Profile of gene transcript changes at 4 weeks. Started Mar 2017; status: completed.
02
Drugs
sirolimusmetformin 1% geldiclofenac
03
Conditions
Skin aging
Beyond the preview
Go deeper on NCT03072485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072485.